T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine
Background: During seasonal influenza epidemics, 5-15% of the population are affected with an illness having a nontrivial mortality, morbidity and economic burden. Inactivated influenza vaccines are routinely used to prevent influenza infection, primarily by inducing humoral immunity. In addition, t...
Principais autores: | Lambe, T, Spencer, A, Mullarkey, C, Antrobus, R, Yu, L, De Whalley, P, Thompson, B, Jones, C, Chalk, J, Kerridge, S, Hill, A, Snape, MD, Pollard, A, Gilbert, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registros relacionados
-
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
por: Lambe, T, et al.
Publicado em: (2012) -
Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.
por: Mullarkey, C, et al.
Publicado em: (2013) -
Immunogenicity and safety of a trivalent inactivated influenza vaccine
por: Eddy Fadlyana, et al.
Publicado em: (2011-02-01) -
Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore
por: Yuk-Fai Lau, et al.
Publicado em: (2017-03-01) -
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
por: Rodrigo Luiz Carregaro, et al.
Publicado em: (2023-08-01)